For: | Yopp AC, Allen PJ. Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2010; 2(10): 359-362 [PMID: 21160844 DOI: 10.4240/wjgs.v2.i10.359] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v2/i10/359.htm |
Number | Citing Articles |
1 |
Charles M Vollmer Jr, Elijah Dixon. Intraductal papillary mucinous neoplasm: Coming of age. World Journal of Gastrointestinal Surgery 2010; 2(10): 299-305 doi: 10.4240/wjgs.v2.i10.299
|
2 |
Wataru Izumo, Ryota Higuchi, Toru Furukawa, Takehisa Yazawa, Shuichiro Uemura, Yutaro Matsunaga, Masahiro Shiihara, Masakazu Yamamoto. Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis. Scandinavian Journal of Gastroenterology 2019; 54(11): 1412 doi: 10.1080/00365521.2019.1684554
|
3 |
Lana Khalil, Zhonglu Huang, Katerina Zakka, Renjian Jiang, McKenna Penley, Olatunji B. Alese, Walid L. Shaib, Christina Wu, Madhusmita Behera, Michelle D. Reid, Bassel F. El-Rayes, Mehmet Akce. Survival and Prognostic Factors in Patients With Pancreatic Colloid Carcinoma Compared With Pancreatic Ductal Adenocarcinoma. Pancreas 2023; 52(1): e75 doi: 10.1097/MPA.0000000000002227
|
4 |
Jacob R. Miller, Juliana E. Meyer, Joshua A. Waters, Mohammad Al-Haddad, John DeWitt, Stuart Sherman, Keith D. Lillemoe, C. Max Schmidt. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB 2011; 13(11): 759 doi: 10.1111/j.1477-2574.2011.00354.x
|
5 |
Jia-Yuan Wu, Yu-Feng Wang, Huan Ma, Sha-Sha Li, Hui-Lai Miao. Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study. World Journal of Gastroenterology 2020; 26(5): 535-549 doi: 10.3748/wjg.v26.i5.535
|
6 |
Zhi Ven Fong, Carlos Fernández-del Castillo. Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy. Visceral Medicine 2015; 31(1): 43 doi: 10.1159/000373912
|
7 |
Zhi Ven Fong, Carlos Fernández-del Castillo. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Surgical Clinics of North America 2016; 96(6): 1431 doi: 10.1016/j.suc.2016.07.009
|
8 |
Giovanni Capretti, Martina Nebbia, Francesca Gavazzi, Gennaro Nappo, Cristina Ridolfi, Mauro Sollai, Paola Spaggiari, Silvia Bozzarelli, Silvia Carrara, Antonio Luberto, Alessandro Zerbi. Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(6): 782 doi: 10.1016/j.pan.2022.05.006
|
9 |
S. Caponi, E. Vasile, N. Funel, N. De Lio, D. Campani, L. Ginocchi, M. Lucchesi, C. Caparello, M. Lencioni, C. Cappelli, F. Costa, L. Pollina, S. Ricci, F. Mosca, A. Falcone, U. Boggi. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. European Journal of Surgical Oncology (EJSO) 2013; 39(4): 396 doi: 10.1016/j.ejso.2012.12.005
|
10 |
Volkan Adsay, Mari Mino-Kenudson, Toru Furukawa, Olca Basturk, Giuseppe Zamboni, Giovanni Marchegiani, Claudio Bassi, Roberto Salvia, Giuseppe Malleo, Salvatore Paiella, Christopher L. Wolfgang, Hanno Matthaei, G. Johan Offerhaus, Mustapha Adham, Marco J. Bruno, Michelle D. Reid, Alyssa Krasinskas, Günter Klöppel, Nobuyuki Ohike, Takuma Tajiri, Kee-Taek Jang, Juan Carlos Roa, Peter Allen, Carlos Fernández-del Castillo, Jin-Young Jang, David S. Klimstra, Ralph H. Hruban. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract. Annals of Surgery 2016; 263(1): 162 doi: 10.1097/SLA.0000000000001173
|
11 |
Vincenzo Nasca, Marta Chiaravalli, Geny Piro, Annachiara Esposito, Lisa Salvatore, Giampaolo Tortora, Vincenzo Corbo, Carmine Carbone. Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification. International Journal of Molecular Sciences 2020; 21(17): 6386 doi: 10.3390/ijms21176386
|
12 |
Shuichi TOBINAGA, Yorihisa SUMIDA, Masato ARAKI, Masaki KUNIZAKI, Keisuke IWASAKI, Hiroshi ISHIKAWA. A CASE OF ADENOSQUAMOUS CARCINOMA OF THE PANCREAS ARISING FROM AN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2011; 72(5): 1272 doi: 10.3919/jjsa.72.1272
|
13 |
Manfred P. Lutz, Georg Kien. Adjuvante Therapie und Nachsorge bei zystischem Malignom. Viszeralmedizin 2011; 27(3): 1 doi: 10.1159/000329331
|
14 |
Chanjuan Shi, Ralph H. Hruban. Intraductal papillary mucinous neoplasm. Human Pathology 2012; 43(1): 1 doi: 10.1016/j.humpath.2011.04.003
|
15 |
N. Regenet, A. Sauvanet, F. Muscari, B. Meunier, C. Mariette, M. Adham, V. Moutardier, J.-R. Delpero, J.-M. Regimbeau, P. Pessaux, F. Paye, A. Sa Cunha, C. Ansquer. Évaluation de la valeur du PET scanner au 18F-FDG dans la différenciation des formes bénignes et malignes des tumeurs intracanalaires papillaire et mucineuse du pancréas. Journal de Chirurgie Viscérale 2020; 157(5): 394 doi: 10.1016/j.jchirv.2019.11.004
|
16 |
Olca Basturk, Volkan Adsay, Gokce Askan, Deepti Dhall, Giuseppe Zamboni, Michio Shimizu, Karina Cymes, Fatima Carneiro, Serdar Balci, Carlie Sigel, Michelle D. Reid, Irene Esposito, Helena Baldaia, Peter Allen, Günter Klöppel, David S. Klimstra. Intraductal Tubulopapillary Neoplasm of the Pancreas. American Journal of Surgical Pathology 2017; 41(3): 313 doi: 10.1097/PAS.0000000000000782
|
17 |
Mathias Worni, Igor Akushevich, Beat Gloor, John Scarborough, Junzo P. Chino, Danny O. Jacobs, Stephen M. Hahn, Bryan M. Clary, Ricardo Pietrobon, Anand Shah. Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: an Analysis of the Surveillance, Epidemiology, and End Results Registry. Annals of Surgical Oncology 2012; 19(4): 1316 doi: 10.1245/s10434-011-2088-2
|
18 |
Matthew K. Iyer, Chanjuan Shi, Austin M. Eckhoff, Ashley Fletcher, Daniel P. Nussbaum, Peter J. Allen. Digital spatial profiling of intraductal papillary mucinous neoplasms: Toward a molecular framework for risk stratification. Science Advances 2023; 9(11) doi: 10.1126/sciadv.ade4582
|
19 |
Zhi Ven Fong, Cristina R. Ferrone, Keith D. Lillemoe, Carlos Fernández-del Castillo. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Annals of Surgery 2016; 263(5): 908 doi: 10.1097/SLA.0000000000001567
|
20 |
Axel Bengtsson, Roland Andersson, Daniel Ansari. Histological variants of pancreatic ductal adenocarcinoma: a survival analysis. Langenbeck's Archives of Surgery 2024; 409(1) doi: 10.1007/s00423-024-03506-6
|
21 |
N. Regenet, A. Sauvanet, F. Muscari, B. Meunier, C. Mariette, M. Adham, V. Moutardier, J.-R. Delpero, J.-M. Regimbeau, P. Pessaux, F. Paye, A. Sa Cunha, C. Ansquer. The value of 18F-FDG positron emission tomography to differentiate benign from malignant intraductal papillary mucinous neoplasms: A prospective multicenter study. Journal of Visceral Surgery 2020; 157(5): 387 doi: 10.1016/j.jviscsurg.2020.01.006
|
22 |
Ajaykumar C. Morani, Abdelrahman K. Hanafy, Nisha S. Ramani, Venkata S. Katabathina, Sireesha Yedururi, Anil K. Dasyam, Srinivasa R. Prasad. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiology: Imaging Cancer 2020; 2(2): e190020 doi: 10.1148/rycan.2020190020
|